A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant

Registration Number
NCT06559709
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

This clinical trial evaluates the impact of a plant-based whole-foods delivery service on the microbiome in patients with multiple myeloma undergoing an autologous hematopoietic cell transplant. An autologous hematopoietic cell transplant is a procedure in which blood-forming stem cells (cells from which all blood cells develop) are removed, stored, and late...

Detailed Description

OUTLINE:

Patients receive 3 meals per day and snacks delivered twice weekly and meet with dietitian once weekly on days -7 to 28. Patients undergo blood and stool sample collection on study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Able to provide written informed consent prior to initiation of any study procedures
  • Planned first autologous stem cell transplantation for multiple myeloma
  • Planned outpatient treatment for the duration of transplantation (if admitted, the investigators will request that caregivers bring the meals/snacks to the hospital as they might with other food prepared at home)
  • Access to a refrigerator
  • Ability to reheat foods
  • Able to consume an oral diet at enrollment
  • Able to communicate clearly regarding aspects of the study: e.g. Give feedback on logistics and meals, in order to maximize the operational data the investigators can gather in this pilot study
  • At least 18 years of age
Read More
Exclusion Criteria
  • Major psychiatric diagnosis that impairs cognitive functioning or is not controlled at the time of the approach, as judged by the patient's medical team
  • Planned inpatient transplantation
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Supportive care (meal delivery service)Biospecimen CollectionPatients receive 3 meals per day and snacks delivered twice weekly and meet with dietitian once weekly on days -7 to 28. Patients undergo blood and stool sample collection on study.
Supportive care (meal delivery service)Dietary InterventionPatients receive 3 meals per day and snacks delivered twice weekly and meet with dietitian once weekly on days -7 to 28. Patients undergo blood and stool sample collection on study.
Supportive care (meal delivery service)Questionnaire AdministrationPatients receive 3 meals per day and snacks delivered twice weekly and meet with dietitian once weekly on days -7 to 28. Patients undergo blood and stool sample collection on study.
Supportive care (meal delivery service)Medical Chart ReviewPatients receive 3 meals per day and snacks delivered twice weekly and meet with dietitian once weekly on days -7 to 28. Patients undergo blood and stool sample collection on study.
Primary Outcome Measures
NameTimeMethod
Tolerability of the delivered diet: Patient opinionUp to 1 month post transplant

Patient opinion of the delivered meals will be assessed using qualitative end-study surveys.

Enrollment rateUp to 1 year

The proportion of eligible patients who consent to enroll in the study will be computed based on the number approached and estimated with 95% confidence intervals. Reasons for non-participation will be summarized.

Collection rateUp to 1 month post transplant

Collection rate will be the percentage of stool samples, blood samples and surveys collected.

Tolerability of the delivered diet: Proportion of meals consumedUp to 1 month post transplant

Patient acceptability of the delivered meals will be assessed using proportions of the delivered meals consumed based on multi-day food diaries and 24-hour recall assessments.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fred Hutch/University of Washington Cancer Consortium

🇺🇸

Seattle, Washington, United States

© Copyright 2024. All Rights Reserved by MedPath